Rosalind Franklin University Doubles Biotech Incubator Space Amid Regional Growth
Event summary
- Rosalind Franklin University expanded its Helix 51 biomedical incubator by 6,000 square feet, doubling its capacity to 13,000 square feet.
- The expansion aims to accommodate up to 10 additional biotechnology startups, bringing the total to 22.
- Helix 51 is the only biomedical incubator in Lake County, Illinois, serving a regional reach from Milwaukee to northern Cook County.
- Recent tenant additions include Saros Therapeutics, DeepBrain, Carobsyn, and the Chicago Clinical Research Institute.
- UP Oncolytics, a current tenant, received designation as a Qualified New Business Venture under the Illinois Angel Investment Tax Credit Program.
The big picture
The expansion of Helix 51 underscores the growing demand for biotech incubation space in the Midwest, reflecting broader trends of regional life sciences clusters gaining prominence. Rosalind Franklin University's strategic focus on disease-focused research strengths aligns with the incubator's mission to support early-stage biotechnology companies. The addition of new tenants and the achievement of milestones by existing companies validate the regional ecosystem's potential to drive innovation and economic growth.
What we're watching
- Regional Hub Dynamics
- Whether Lake County can sustain its position as a Midwest bioscience hub amid increasing competition from other regional clusters.
- Talent Attraction
- How the expansion will impact the ability to attract and retain top biotech talent in the region.
- Commercialization Success
- The pace at which startups within Helix 51 achieve commercialization milestones and secure additional funding.
Related topics